OncoSignal
Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:19 UTC. Every row links to its source record.

Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time

Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone

NCT05299398 · Verinder Sharma · PHASE1 · withdrawn · last registry update 2025-04-04 · Decision brief

No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.

What was said, and by whom

Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.

KindQuoteOur categorySource
Stated“This study was pivoted to be a randomized control trial of trazodone versus quetiapine, under a new NTC identification number (study protocol number 125638).”–Registry record, Verinder Sharma

Also happening at the time. Not shown to be a cause.

Registry events on other trials of drugs against SLC6A4 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.

What is not public

  • Internal portfolio and board discussions
  • Unpublished trial data and interim analyses
  • Terms of any partner or licence decision